← Leaderboards
Beth Y. Karlan
La Biomed Res Inst/ Harbor Ucla Med Ctr
$403,700
Attributed
$750,901
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $149.1K · FY2005–13$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$750,901 · 8
By mechanism
P50$694,402 · 1
M01$56,499 · 7
Top collaborators
- Nicole D. Urban5 shared
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- C. Noel Bairey Merz$16,199,798
Others in their field
Top investigators on “Institution”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,187,810,557
- Leonard Freedman · Leidos Biomedical Research, Inc.$835,530,754
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$566,554,288
- Bambra Strokes · Ppd Development Lp$526,656,217
Research focus
InstitutionMalignant Neoplasm Of OvaryWomanStagingMortality Vital StatisticsScreening ProcedureDiagnosisMalignant NeoplasmsOvarianEarly DiagnosisBrca1 GeneFutureEpithelial Ovarian CancerModalityClinical Research SiteCostCost EffectivenessCaliforniaCa-125 AntigenAnticancer ResearchEligibility DeterminationColonCitiesAlgorithms
Grant awards (14)
Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women$138,833
P50 · FY2013 · CA
Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women$147,635
P50 · FY2012 · CA
Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women$114,878
P50 · FY2011 · CA
Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women$143,955
P50 · FY2010 · CA
Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women$149,101
P50 · FY2009 · CA
BLOOD AND TISSUE BANKING IN GYNECOLOGICAL MALIGNANCIES$2,193
M01 · FY2008 · RR · contact PI
BLOOD AND TISSUE BANKING IN GYNECOLOGICAL MALIGNANCIES$3,347
M01 · FY2007 · RR · contact PI
OVARIAN TISSUE AND CLINICAL DATABASE CORE FACILITY$107
M01 · FY2007 · RR · contact PI
GENETIC DEFINITION AND PHENOTYPE DETERMINANTS OF HUMAN OVARIAN CARCINOMA$6,171
M01 · FY2006 · RR · contact PI
BLOOD AND TISSUE BANKING IN GYNECOLOGIC MALIGNANCIES$6,171
M01 · FY2006 · RR · contact PI
BLOOD AND TISSUE BANKING IN GYNECOLOGIC MALIGNANCIES$4,539
M01 · FY2005 · RR
GENETIC DEFINITION AND PHENOTYPE DETERMINANTS OF HUMAN OVARIAN CARCINOMA$4,445
M01 · FY2005 · RR
Blood and Tissue Banking in Gynecologic Malignancies$15,405
M01 · FY2004 · RR
Genetic Definition and Phenotype Determinants of Human Ovarian Carcinoma$14,121
M01 · FY2004 · RR